---
pmid: '35027735'
title: PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
authors:
- Zhang HL
- Hu BX
- Li ZL
- Du T
- Shan JL
- Ye ZP
- Peng XD
- Li X
- Huang Y
- Zhu XY
- Chen YH
- Feng GK
- Yang D
- Deng R
- Zhu XF
journal: Nat Cell Biol
year: '2022'
full_text_available: false
doi: 10.1038/s41556-021-00818-3
---

# PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
**Authors:** Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP, Peng XD, Li X, Huang Y, Zhu XY, Chen YH, Feng GK, Yang D, Deng R, Zhu XF
**Journal:** Nat Cell Biol (2022)
**DOI:** [10.1038/s41556-021-00818-3](https://doi.org/10.1038/s41556-021-00818-3)

## Abstract

1. Nat Cell Biol. 2022 Jan;24(1):88-98. doi: 10.1038/s41556-021-00818-3. Epub
2022  Jan 13.

PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.

Zhang HL(1), Hu BX(1), Li ZL(1), Du T(1)(2), Shan JL(1), Ye ZP(1), Peng XD(1), 
Li X(1), Huang Y(1), Zhu XY(1), Chen YH(1), Feng GK(1), Yang D(1), Deng R(3), 
Zhu XF(4).

Author information:
(1)State Key Laboratory of Oncology in South China, Collaborative Innovation 
Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma 
Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
(2)Department of Breast Oncology, Sun Yat-sen University Cancer Center, 
Guangzhou, China.
(3)State Key Laboratory of Oncology in South China, Collaborative Innovation 
Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma 
Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China. 
dengrong@sysucc.org.cn.
(4)State Key Laboratory of Oncology in South China, Collaborative Innovation 
Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma 
Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China. 
zhuxfeng@mail.sysu.edu.cn.

Comment in
    Nat Cell Biol. 2022 Jan;24(1):4-5. doi: 10.1038/s41556-021-00824-5.

The accumulation of lipid peroxides is recognized as a determinant of the 
occurrence of ferroptosis. However, the sensors and amplifying process of lipid 
peroxidation linked to ferroptosis remain obscure. Here we identify PKCβII as a 
critical contributor of ferroptosis through independent genome-wide CRISPR-Cas9 
and kinase inhibitor library screening. Our results show that PKCβII senses the 
initial lipid peroxides and amplifies lipid peroxidation linked to ferroptosis 
through phosphorylation and activation of ACSL4. Lipidomics analysis shows that 
activated ACSL4 catalyses polyunsaturated fatty acid-containing lipid 
biosynthesis and promotes the accumulation of lipid peroxidation products, 
leading to ferroptosis. Attenuation of the PKCβII-ACSL4 pathway effectively 
blocks ferroptosis in vitro and impairs ferroptosis-associated cancer 
immunotherapy in vivo. Our results identify PKCβII as a sensor of lipid 
peroxidation, and the lipid peroxidation-PKCβII-ACSL4 positive-feedback axis may 
provide potential targets for ferroptosis-associated disease treatment.

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

DOI: 10.1038/s41556-021-00818-3
PMID: 35027735 [Indexed for MEDLINE]
